Synthetic Bio Pioneer Ginkgo Raises $70 Million to Tackle Covid-19 Testing

(Bloomberg) -- Ginkgo Bioworks Inc. has raised $70 million in an effort to build out DNA-based Covid-19 testing on a massive scale.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.